Market revenue in 2023 | USD 15,576.7 million |
Market revenue in 2030 | USD 29,468.7 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Equipment |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Equipment, Services |
Key market players worldwide | B. Braun, Abbott Laboratories, Sunrise Medical, 3M Co, Baxter International Inc, Medtronic PLC, Cardinal Health Inc, Roche Holding AG ADR, Air Liquide SA, Amedisys Inc, Fresenius Medical Care AG, Arkray, Becton Dickinson & Co, OMRON Corp, Drive Medical, GE Aerospace, Medline Industries, Koninklijke Philips NV, Johnson & Johnson, Linde PLC, Vygon, Teleflex Inc, Moog Inc A, Fresenius SE & Co KGaA, Bayer AG, UnitedHealth Group Inc, Brookdale Senior Living Inc, Sunrise Senior Living, Genesis Healthcare Inc Class A, Extendicare Inc, Sonida Senior Living Inc, Home Instead |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home healthcare market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 84.28% in 2023. Horizon Databook has segmented the China home healthcare market based on equipment, services covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of chronic disorders and growing geriatric population are some of the major factors contributing to the growth of China Home Healthcare market. As a result of these factors, the demand for Home Healthcare in China has increased over time. In China, the prevalence of cardiovascular diseases has increased in recent decades.
According to a 2019 report published in JAMA Cardiology by Liu S et al., the prevalence of these diseases has more than doubled since 1990, reaching almost 94 million in 2016. As a result, the usage of patient monitoring devices for cardiology applications has increased, which is expected to further grow, thereby driving the overall market growth.
For instance, in December 2018, GE Healthcare partnered with Lonza to establish a biologics facility in China. This helped the company expand its geographic reach while decreasing operating costs.
Horizon Databook provides a detailed overview of country-level data and insights on the China home healthcare market , including forecasts for subscribers. This country databook contains high-level insights into China home healthcare market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account